Nonprofit · EIN 13-1837442
CANCER RESEARCH INSTITUTE INC
Tax-exempt · NEW YORK, NY 10006
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $35,485,656 | $42,146,188 | -$6,660,532 | $129,632,160 | $44,752,449 | $84,879,711 |
| June 30, 2024 | 990 | $23,964,638 | $32,820,896 | -$8,856,258 | $133,734,670 | $66,904,035 | $66,830,635 |
| June 30, 2023 | 990 | $32,295,259 | $38,552,663 | -$6,257,404 | $138,008,864 | $70,013,010 | $67,995,854 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $26,698,175
- Program service revenue
- $907,299
- Investment income
- $7,801,595
- Net rental income
- $49,095
- Net gain from sales of assets
- $6,037,213
- Other revenue
- $78,587
Expenses
- Grants and similar amounts paid
- $28,527,085
- Compensation of officers, directors and key employees
- $2,934,280
- Other salaries and wages
- $2,558,629
- Salaries, compensation and benefits (total)
- $7,014,995
- Professional fundraising fees
- $0
- Legal fees
- $97,635
- Accounting fees
- $147,105
- Occupancy
- $535,388
- Travel
- $266,441
- Depreciation
- $44,843
- Program services (functional)
- $33,376,963
- Management and general (functional)
- $3,914,001
- Fundraising (functional)
- $4,855,224
Balance sheet and other
- Total assets, start of year
- $133,734,670
- Total assets, end of year
- $129,632,160
- Total liabilities, end of year
- $44,752,449
- Net assets, end of year
- $84,879,711
- Land, buildings and equipment
- $205,402
- Publicly traded securities
- $18,681,322
- Net assets without donor restrictions
- $70,295,173
- Net assets with donor restrictions
- $14,584,538
- Gross receipts
- $54,923,244
- Employees
- 31
- Volunteers
- 130
- Year formed
- 1953
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JILL O'DONNELL-TORMEY PHD | FORMER CEO (THRU 8/2024) Officer | 40 | $674,070 | $73,665 |
| ALFRED R MASSIDAS | FORMER CFO (THRU 2/2025) Officer | 40 | $452,220 | $90,323 |
| LYNNE A RAPINO | CHIEF PROGRAM OFFICER Key employee | 40 | $353,253 | $90,304 |
| SHARON S SLADE | CHIEF MARKETING OFFICER Key employee | 40 | $377,547 | $53,116 |
| JAY R CAMPBELL | MANAGING DIR OF CRI CLINICAL ACCELERATOR Key employee | 40 | $311,472 | $81,656 |
| RUPINDER KAUR THRU 12025 | CHIEF INFORMATION OFFICER Key employee | 40 | $295,750 | $68,646 |
| ALICIA ZHOU START 82024 | CHIEF EXECUTIVE OFFICER Officer | 40 | $241,026 | $0 |
| SAMIK K UPADHAYA | DIRECTOR OF SCIENTIFIC AFFAIRS Highest-paid employee | 40 | $182,450 | $57,290 |
| KASTURI SHARMA | ASSISTANT DIRECTOR, DONATION PROCESSING Highest-paid employee | 40 | $200,751 | $34,615 |
| DEANNE T MARBACH | DIRECTOR OF MAJOR GIFT Highest-paid employee | 40 | $178,417 | $56,918 |
| QING HUA ZHANG THRU 12025 | CONTROLLER Highest-paid employee | 40 | $177,070 | $56,824 |
| SHASELL NEGRON | ASSOC DIR, PROGRAM MANAGEMENT Highest-paid employee | 40 | $152,270 | $35,369 |
| KATHRYN BEELEY START 112024 | CHIEF FINANCIAL OFFICER Officer | 40 | $21,000 | $0 |
| ANDREW K TSAI | CHAIRMEN Trustee or director, Officer | 3.5 | $0 | $0 |
| DONALD J GOGEL | VICE CHAIRMEN Trustee or director, Officer | 1 | $0 | $0 |
32 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ANTONIO C ALVAREZ II | TRUSTEE Trustee or director | 1 | $0 |
| YACOV ARNOPOLIN | TRUSTEE Trustee or director | 5 | $0 |
| EDGAR R BERNER | TRUSTEE Trustee or director | 1 | $0 |
| MEGAN LEARY BETHKE | TRUSTEE Trustee or director | 1 | $0 |
| PETER L BLOOM | TRUSTEE Trustee or director | 1 | $0 |
| BRIAN J BRILLE | TRUSTEE Trustee or director | 1 | $0 |
| GEOFFREY O COLEY | TRUSTEE Trustee or director | 1 | $0 |
| SANDRA COUDERT GRAHAM | TRUSTEE Trustee or director | 1 | $0 |
| ROBERT DAHL | TRUSTEE Trustee or director | 1 | $0 |
| MAXWELL DAVID | TRUSTEE Trustee or director | 1 | $0 |
| SEAN P FAHEY | TRUSTEE (THRU 7/2024) Trustee or director | 1 | $0 |
| WILLIAM S GOLDBERG | TRUSTEE Trustee or director | 1 | $0 |
| OLIVER R GRACE JR | TRUSTEE Trustee or director | 1 | $0 |
| MICHAEL M KELLEN | TRUSTEE Trustee or director | 1 | $0 |
| SARAH KIM | TRUSTEE Trustee or director | 1 | $0 |
| FERN LAZAR | TRUSTEE Trustee or director | 1 | $0 |
| MITRA LOHRASBPOUR | TRUSTEE Trustee or director | 1 | $0 |
| SANDRA OZOLA | TRUSTEE Trustee or director | 1 | $0 |
| THOMAS G MENDELL | TRUSTEE Trustee or director | 1 | $0 |
| MICHAEL J PETRICK | TRUSTEE Trustee or director | 1 | $0 |
| LIEF D ROSENBLATT | TRUSTEE Trustee or director | 1 | $0 |
| ADAM J SHAPIRO | TRUSTEE Trustee or director | 1 | $0 |
| ANAND SHAH | TRUSTEE Trustee or director | 1 | $0 |
| FRANK V SICA | TRUSTEE Trustee or director | 1 | $0 |
| JAMES A STERN | TRUSTEE Trustee or director | 1 | $0 |
| ROBERT S STOLAR | TRUSTEE Trustee or director | 1 | $0 |
| MICHAEL B TARGOFF | TRUSTEE Trustee or director | 1 | $0 |
| DIANE TUFT | TRUSTEE Trustee or director | 1 | $0 |
| LAUREN S VERONIS | TRUSTEE Trustee or director | 1 | $0 |
| RONALD G WEINER | TRUSTEE Trustee or director | 1 | $0 |
| JIM WEISS | TRUSTEE Trustee or director | 1 | $0 |
| PETER ZHOU | TRUSTEE Trustee or director | 1 | $0 |
990 for the year ended June 30, 2024: 50 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JILL O'DONNELL TORMEY TO 824 | CEO & DIRECTOR OF SCIENTIFIC AFFAIRS Officer | 40 | $539,137 | $72,884 |
| ALFRED R MASSIDAS TO 22025 | CFO & DIRECTOR OF HUMAN RESOURCES Officer | 40 | $347,437 | $90,161 |
| LYNNE A RAPINO | CHIEF PROGRAM OFFICER Key employee | 40 | $287,287 | $84,627 |
| JAY R CAMPBELL | MANAGING DIR OF CRI CLINICAL ACCELERATOR Key employee | 40 | $284,937 | $83,161 |
| SHARON S SLADE | CHIEF MARKETING OFFICER Key employee | 40 | $273,403 | $47,760 |
| RUPINDER KAUR | CHIEF INFORMATION OFFICER Key employee | 40 | $247,910 | $64,351 |
| DEANNE T MARBACH | DIRECTOR OF MAJOR GIFTS Key employee | 40 | $155,690 | $54,575 |
| QING HUA ZHANG | CONTROLLER Highest-paid employee | 40 | $147,203 | $53,996 |
| SAMIK K UPADHAYA | ASST DIRECTOR, SCIENTIFIC AFFAIRS Highest-paid employee | 40 | $145,770 | $54,210 |
| MARLA S LAWSON | ASSOC DIR OF CORPORATE RELATIONS Highest-paid employee | 40 | $136,015 | $52,016 |
| SHASELL NEGRON | ASSOC DIR, COMMUNITY FUNDRAISING Highest-paid employee | 40 | $126,437 | $32,999 |
| BRIAN M BREWER | CHIEF COMMUNICATIONS OFFICER Highest-paid employee | 40 | $148,135 | $0 |
| PAUL C SHIVERICK | CHAIRMEN Trustee or director, Officer | 5 | $0 | $0 |
| ANDREW K TSAI | CHAIRMEN Trustee or director, Officer | 5 | $0 | $0 |
| DONALD J GOGEL | VICE CHAIRMEN Trustee or director, Officer | 3 | $0 | $0 |
| EDGAR R BERNER | VICE CHAIRMEN Trustee or director, Officer | 3 | $0 | $0 |
| GEOFFREY O COLEY | TREASURER Trustee or director, Officer | 3 | $0 | $0 |
| THOMAS G MENDELL | SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| TONY ALVAREZ II | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| YACOV ARNOPOLIN | TRUSTEE Trustee or director | 4 | $0 | $0 |
| PETER L BLOOM | TRUSTEE Trustee or director | 4 | $0 | $0 |
| BRIAN J BRILLE | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MICHAEL R CRAWFORD | TRUSTEE (THRU 4/2024) Trustee or director | 1 | $0 | $0 |
| W ROBERT DAHL | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MAXWELL DAVID | TRUSTEE Trustee or director | 0.25 | $0 | $0 |
| GLENN J DESIMONE | TRUSTEE (THRU 7/2023) Trustee or director | 1 | $0 | $0 |
| SEAN P FAHEY | TRUSTEE Trustee or director | 1 | $0 | $0 |
| WILLIAM S GOLDBERG | TRUSTEE Trustee or director | 0.25 | $0 | $0 |
| OLIVER R GRACE JR | TRUSTEE Trustee or director | 1 | $0 | $0 |
| SANDRA COUDERT GRAHAM | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| MICHAEL M KELLEN | TRUSTEE Trustee or director | 1 | $0 | $0 |
| SARAH KIM | TRUSTEE Trustee or director | 3 | $0 | $0 |
| FERN LAZAR | TRUSTEE Trustee or director | 3 | $0 | $0 |
| ALEXANDER P LYNCH | TRUSTEE (THRU 7/2023) Trustee or director | 1 | $0 | $0 |
| SANDRA OZOLA | TRUSTEE Trustee or director | 0.25 | $0 | $0 |
| MICHAEL J PETRICK | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| LIEF D ROSENBLATT | TRUSTEE Trustee or director | 0.25 | $0 | $0 |
| ANAND SHAH MD | TRUSTEE Trustee or director | 0.25 | $0 | $0 |
| ADAM SHAPIRO | TRUSTEE Trustee or director | 0.25 | $0 | $0 |
| FRANK V SICA | TRUSTEE Trustee or director | 1 | $0 | $0 |
| JAMES A STERN | TRUSTEE Trustee or director | 1 | $0 | $0 |
| ROBERT S STOLAR | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MICHAEL B TARGOFF | TRUSTEE Trustee or director | 1 | $0 | $0 |
| DIANE TUFT | TRUSTEE Trustee or director | 1 | $0 | $0 |
| LAUREN S VERONIS | TRUSTEE Trustee or director | 3 | $0 | $0 |
| RONALD G WEINER | TRUSTEE Trustee or director | 1 | $0 | $0 |
| JIM WEISS | TRUSTEE Trustee or director | 4 | $0 | $0 |
| PETER ZHOU | TRUSTEE Trustee or director | 5 | $0 | $0 |
| ALICIA ZHOU PHD START 92024 | CEO Officer | 40 | $0 | $0 |
| KATHRYN BEELEY START 22025 | CFO Officer | 40 | $0 | $0 |
990 for the year ended June 30, 2023: 47 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JILL O'DONNELL-TORMEY PHD | CEO/DIR. OF SCIENTIFIC AFFAIRS Officer | 40 | $531,286 | $71,017 |
| ALFRED R MASSIDAS | CFO/DIR. OF HUMAN RESOURCES Officer | 40 | $342,586 | $83,215 |
| LYNNE A RAPINO | CHIEF PROGRAM OFFICER Key employee | 40 | $283,374 | $80,930 |
| JAY R CAMPBELL | MANAGING DIR. OF CRI CLINICAL ACCELERATOR AND VENT Key employee | 40 | $274,937 | $80,466 |
| SHARON S SLADE | CHIEF MARKETING OFFICER Key employee | 40 | $259,188 | $46,322 |
| RUPINDER KAUR | CHIEF INFORMATION OFFICER Key employee | 40 | $224,014 | $61,474 |
| BRIAN M BREWER | CHIEF COMMUNICATIONS OFFICER Key employee | 40 | $206,106 | $41,493 |
| BRIAN R LEIDY | CHIEF DEVELOPMENT OFFICER Highest-paid employee | 40 | $199,545 | $29,070 |
| DEANNE T MARBACH | DIRECTOR OF MAJOR GIFTS Highest-paid employee | 40 | $149,175 | $51,949 |
| QING HUA ZHANG | CONTROLLER Highest-paid employee | 40 | $140,888 | $50,907 |
| SAMIK K UPADHAYA | ASST. DIR. OF SCIENTIFIC AFFAIRS Highest-paid employee | 40 | $130,644 | $50,413 |
| MARLA S LAWSON | ASSOC. DIR. OF CORPORATE AND FOUNDATION RELATIONS Highest-paid employee | 40 | $130,597 | $49,766 |
| PAUL C SHIVERICK | CHAIRMAN Trustee or director, Officer | 4 | $0 | $0 |
| ANDREW K TSAI | CHAIRMAN Trustee or director, Officer | 4 | $0 | $0 |
| EDGAR R BERNER | VICE CHAIRMAN Trustee or director, Officer | 3 | $0 | $0 |
| DONALD J GOGEL | VICE CHAIRMAN Trustee or director, Officer | 3 | $0 | $0 |
| ANDREW M PAUL | VICE CHAIRMAN Trustee or director, Officer | 3 | $0 | $0 |
| GEOFFREY O COLEY | TREASURER Trustee or director, Officer | 3 | $0 | $0 |
| THOMAS G MENDELL | SECRETARY Trustee or director, Officer | 1 | $0 | $0 |
| TONY ALVAREZ II | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| YACOV ARNOPOLIN | TRUSTEE Trustee or director | 3 | $0 | $0 |
| PETER L BLOOM | TRUSTEE Trustee or director | 1 | $0 | $0 |
| BRIAN J BRILLE | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MICHAEL R CRAWFORD | TRUSTEE Trustee or director | 1 | $0 | $0 |
| W ROBERT DAHL | TRUSTEE Trustee or director | 1 | $0 | $0 |
| GLENN J DESIMONE | TRUSTEE Trustee or director | 2 | $0 | $0 |
| SEAN P FAHEY | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MARGOT E FREEDMAN | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| WILLIAM S GOLDBERG | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| OLIVER R GRACE JR | TRUSTEE Trustee or director | 1 | $0 | $0 |
| SANDRA COUDERT GRAHAM | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MICHAEL M KELLEN | TRUSTEE Trustee or director | 2 | $0 | $0 |
| SARAH KIM | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MITRA LOHRASBPOUR | TRUSTEE (THRU 1/2023) Trustee or director | 2 | $0 | $0 |
| ALEXANDER P LYNCH | TRUSTEE Trustee or director | 1 | $0 | $0 |
| ALEX MISHUROV | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| MICHAEL J PETRICK | TRUSTEE Trustee or director | 0.5 | $0 | $0 |
| LIEF D ROSENBLATT | TRUSTEE Trustee or director | 1 | $0 | $0 |
| FRANK VSICA | TRUSTEE Trustee or director | 1 | $0 | $0 |
| JAMES A STERN | TRUSTEE Trustee or director | 1 | $0 | $0 |
| ROBERT S STOLAR | TRUSTEE Trustee or director | 1 | $0 | $0 |
| MICHAEL B TARGOFF | TRUSTEE Trustee or director | 1 | $0 | $0 |
| DIANE TUFT | TRUSTEE Trustee or director | 1 | $0 | $0 |
| LAUREN SVERONIS | TRUSTEE Trustee or director | 3 | $0 | $0 |
| RONALD G WEINER | TRUSTEE Trustee or director | 1 | $0 | $0 |
| JIM WEISS | TRUSTEE Trustee or director | 2 | $0 | $0 |
| PETER ZHOU | TRUSTEE Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 29 BROADWAY 4TH FLOOR, NEW YORK, NY 10006-3201
- In care of
- % ALFRED MASSIDAS
- Principal officer (990 for 2024)
- ALICIA ZHOU PHD, 29 BROADWAY 4TH FLOOR, NEW YORK, NY 10006
- Signed the 990
- KATHRYN BEELEY, CFO
- Phone
- (212) 688-7515
- Website
- WWW.CANCERRESEARCH.ORG
- Return prepared by
- EISNER ADVISORY GROUP LLC
Mission
SEE SCHEDULE OCRI IS A NONPROFIT ORGANIZATION DEDICATED TO ADVANCING CANCER IMMUNOTHERAPY THROUGH SCIENTIFIC DISCOVERY AND GLOBAL COLLABORATION. SINCE 1953, CRI HAS FUNDED RESEARCH THAT DEEPENS UNDERSTANDING OF THE IMMUNE SYSTEM AND ITS ROLE IN CANCER, LEADING TO BREAKTHROUGHS SUCH AS CHECKPOINT BLOCKADE AND CELL-BASED THERAPIES. THROUGH INVESTMENTS IN SCIENCE, DATA, AND THE RESEARCH COMMUNITY, CRI WORKS TO TRANSLATE DISCOVERIES INTO EFFECTIVE TREATMENTS FOR PATIENTS.
Program accomplishments
- RESEARCH: CAREER DEVELOPMENT AWARDS + TRANSLATIONAL INNOVATION AND CLINICAL IMPACT AWARDS - SEE SCHEDULE OCRI SUPPORTS WORLD-CLASS SCIENTISTS ACROSS CAREER STAGES TO DRIVE DISCOVERY IN CANCER IMMUNOLOGY AND IMMUNOTHERAPY. CAREER DEVELOPMENT AWARDS, INCLUDING POSTDOCTORAL FELLOWSHIPS AND THE LLOYD J. OLD STAR PROGRAM, PROVIDE FLEXIBLE, MULTI-YEAR FUNDING TO EMERGING AND ESTABLISHED INVESTIGATORS PURSUING HIGH-IMPACT, INNOVATIVE RESEARCH. AWARDS RANGE FROM APPROXIMATELY $243,000 OVER THREE YEARS FOR FELLOWSHIPS TO $1.25 MILLION OVER FIVE YEARS FOR STARS. TRANSLATIONAL INNOVATION AND CLINICAL IMPACT AWARDS, INCLUDING CLIP (CLINIC AND LABORATORY INTEGRATION PROGRAM) GRANTS (UP TO $300,000 OVER TWO YEARS) AND TECHNOLOGY IMPACT AWARDS (UP TO $300,000 OVER TWO YEARS) SUPPORT PROJECTS THAT DEEPEN UNDERSTANDING OF TUMOR-IMMUNE INTERACTIONS AND ADVANCE NEW IMMUNOTHERAPEUTIC STRATEGIES TOWARD CLINICAL APPLICATION.Expenses $25,787,340 · grants $21,770,136 · revenue $907,299
- CLINICAL - SEE SCHEDULE OCRI ACCELERATES THE DEVELOPMENT OF PROMISING IMMUNOTHERAPIES THROUGH EARLY-PHASE CLINICAL RESEARCH AND COLLABORATIVE TRIALS. THE CLINICAL INNOVATOR PROGRAM SUPPORTS NOVEL CLINICAL STUDIES WITH FUNDING OF UP TO $1 MILLION PER TRIAL, WHILE THE CLINICAL ACCELERATOR IS AN ACTIVELY MANAGED VENTURE PHILANTHROPY PROGRAM THAT DESIGNS AND CONDUCTS DATA-DRIVEN, MULTI-PARTNER CLINICAL STUDIES IN AREAS OF HIGH UNMET NEED.Expenses $4,446,746 · grants $4,202,418
- DATA - SEE SCHEDULE OCRI ADVANCES THE USE OF DATA TO ENABLE DISCOVERY, TRANSLATION, AND CROSS-STUDY LEARNING IN IMMUNOTHERAPY RESEARCH. THROUGH SUPPORT FOR DATA RESOURCES, ANALYTIC TOOLS, AND COMMUNITY GUIDANCE, CRI SUPPORTS INITIATIVES THAT IMPROVE DATA QUALITY, STANDARDIZATION, AND INTEROPERABILITY ACROSS THE FIELD. THESE EFFORTS HELP UNLOCK INSIGHTS INTO RESPONSE AND RESISTANCE AND GUIDE MORE EFFECTIVE DEVELOPMENT OF IMMUNOTHERAPIES.Expenses $2,851,974 · grants $2,554,531
- PATIENT & POLICY:CRI PROVIDES EDUCATION AND ENGAGEMENT TO IMPROVE PATIENT UNDERSTANDING OF IMMUNOTHERAPY AND SUPPORT INFORMED DECISION-MAKING. THROUGH DIGITAL CONTENT, EVENTS, AND MEDIA OUTREACH, CRI REACHES PATIENTS, CAREGIVERS, AND STAKEHOLDERS WITH ACCESSIBLE SCIENTIFIC AND MEDICAL INFORMATION, INCLUDING RESOURCES IN MULTIPLE LANGUAGES. CRI ALSO CONTRIBUTES TO FIELD-BUILDING BY CONVENING STAKEHOLDERS AND SUPPORTING EFFORTS THAT IMPROVE ACCESS TO AND DELIVERY OF IMMUNOTHERAPIES.Expenses $290,903
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 13-1837442
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1953
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H300)
- Assets (IRS master file)
- $129,632,160
- Income (IRS master file)
- $54,923,244
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $35,485,656 | $42,146,188 | $129,632,160 | IRS |
| 990-T | June 2025 | – | – | – | IRS |
| 990 | June 2024 | $23,964,638 | $32,820,896 | $133,734,670 | XML |
| 990-T | June 2024 | – | – | – | IRS |
| 990 | June 2023 | $32,295,259 | $38,552,663 | $138,008,864 | XML |
| 990-T | June 2023 | – | – | – | IRS |
| 990 | June 2022 | $33,675,150 | $31,314,716 | $130,438,312 | IRS |
| 990-T | June 2022 | – | – | – | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990-T | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2019 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-1837442).
Questions about CANCER RESEARCH INSTITUTE INC
- What is the EIN of CANCER RESEARCH INSTITUTE INC?
- The employer identification number (EIN) of CANCER RESEARCH INSTITUTE INC is 13-1837442.
- Is CANCER RESEARCH INSTITUTE INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1953.
- Are donations to CANCER RESEARCH INSTITUTE INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does CANCER RESEARCH INSTITUTE INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of CANCER RESEARCH INSTITUTE INC due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CANCER RESEARCH INSTITUTE INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of CANCER RESEARCH INSTITUTE INC?
- The 990 for the year ended June 30, 2025 names ALICIA ZHOU PHD.
- Who are the officers and directors of CANCER RESEARCH INSTITUTE INC?
- The 990 for the year ended June 30, 2025 lists 47 people; 13 received compensation from the organization, the highest $674,070 (JILL O'DONNELL-TORMEY PHD, FORMER CEO (THRU 8/2024)).
- How much revenue does CANCER RESEARCH INSTITUTE INC have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $35,485,656, expenses of $42,146,188 and total assets of $129,632,160 at year end.
Other nonprofits in NEW YORK
- MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH EIN 13-4141945 · last filed 990 for 2025
- PUBLIC HEALTH SOLUTIONS EIN 13-5669201 · last filed 990 for 2025
- PARKINSONS FOUNDATION INC EIN 13-1866796 · last filed 990 for 2025
- LICR FUND INC EIN 13-3573053 · last filed 990 for 2024
- CARDIOVASCULAR RESEARCH FOUNDATION EIN 52-1752653 · last filed 990 for 2024
- GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC EIN 13-4128413 · last filed 990 for 2024
- INTERNATIONAL BRAIN RESEARCH ORGANIZATION EIN 88-4372025 · last filed 990 for 2024
- THE FOUNDATION FOR AIDS RESEARCH EIN 13-3163817 · last filed 990 for 2025